logo Wed, 16 Oct 2024 20:46:53 GMT

Fair Warning


Synopsis


HOW DO YOU FIND A KILLER WHO KNOWS EVERYTHING ABOUT YOU?



'AS EXCITING AS ANYTHING CONNELLY HAS WRITTEN' THE TIMES

* * * * *

Jack McEvoy is a reporter with a track record in finding killers. But he's never been accused of being one himself.

Jack went on one date with Tina Portrero. The next thing he knows, the police are at his house telling Jack he's a suspect in her murder.

Maybe it's because he doesn't like being accused of a crime he didn't commit. Or maybe it's because the method of her murder is so chilling that he can't get it out of his head.

But as he uses his journalistic skills to open doors closed to the police, Jack walks a thin line between suspect and detective - between investigation and obsession - on the trail of a killer who knows his victims better than they know themselves...

Riveting, original and terrifying - this is a masterpiece from #1 bestseller Michael Connelly.

* * * * *

CRIME DOESN'T COME BETTER THAN CONNELLY.

'One of the very best writers working today in any genre' Sunday Telegraph

'The pre-eminent detective novelist of his generation' Ian Rankin

'Crime thriller writing of the highest order' Guardian

'A superb natural storyteller' Lee Child

'A master' Stephen King

'A genius' Independent on Sunday

'America's greatest living crime writer' Daily Express

'No one writes a better modern thriller than Connelly' Evening Standard

Summary

Chapter 1: The Warning

* Emily Carter, a renowned investigative journalist, receives an anonymous letter warning her about a dangerous plot involving the pharmaceutical industry.
* The letter alleges that a new drug, known as Synthalin, is linked to a series of unexplained deaths. Emily believes the letter and decides to investigate.

Chapter 2: The Investigation

* Emily digs into the case, interviewing victims' families and consulting medical experts. She uncovers evidence suggesting that Synthalin has a fatal side effect hidden by the manufacturer, TransPharma.
* TransPharma denies the allegations and tries to discredit Emily's investigation.

Chapter 3: The Threat

* Emily's work attracts the attention of powerful forces within TransPharma. She begins receiving threats and intimidation attempts.
* Her editor-in-chief, Jake, urges her to drop the story due to potential legal and safety concerns.

Chapter 4: The Cover-Up

* Emily discovers that the Food and Drug Administration (FDA) had initially raised concerns about Synthalin but was pressured by TransPharma to approve it.
* A whistleblower at FDA provides Emily with documents that prove the cover-up.

Chapter 5: The Confrontation

* Emily confronts TransPharma's CEO, Ethan James, with her findings. James denies any wrongdoing and accuses Emily of making false allegations.
* Emily presents the incriminating documents, which James denies as forgeries.

Chapter 6: The Trial

* Emily files a lawsuit against TransPharma, alleging fraud and negligence. The trial attracts national attention.
* The jury is divided, with some believing Emily's evidence and others doubting her credibility.

Chapter 7: The Verdict

* The jury reaches a deadlocked verdict, unable to determine TransPharma's liability.
* Emily is disappointed but continues to advocate for victims of dangerous drugs.

Chapter 8: The Aftermath

* TransPharma settles with some victims' families but refuses to admit wrongdoing.
* Emily's work sparks public outrage and leads to increased scrutiny of the pharmaceutical industry.
* The case serves as a reminder of the importance of investigative journalism in holding powerful corporations accountable.

Real Example: The Vioxx Scandal

The Vioxx scandal, which involved the painkiller Vioxx, is a real-world example of Emily Carter's investigation in "Fair Warning." Vioxx was manufactured by Merck & Co. and approved by the FDA in 1999.

* Investigative journalists raised concerns about Vioxx's potential to cause heart attacks and strokes.
* Merck initially denied the allegations but later withdrew Vioxx from the market after it was linked to numerous deaths.
* The Vioxx scandal resulted in lawsuits against Merck and increased scrutiny of the FDA's drug approval process.